Postpenetrating Keratoplasty Glaucoma-Risk Factors, Management, and Visual Outcome

Descemetʼs stripping with automated endothelial keratoplasty and glaucoma

“…Preexisting glaucoma has been reported to increase the relative risk of developing postkeratoplasty glaucoma four-fold [17]. The indication for PKP has a large impact on developing postkeratoplasty glaucoma [17][18][19][20][21]. Development of postkeratoplasty glaucoma is significant because it is a leading risk factor for graft failure and irreversible vision loss [22,23 ].…”

Prise en charge thérapeutique d’une hypertonie oculaire post-kératoplastie transfixiante : à propos de 73 cas

“…En effet, le traitement médical représente la première étape de notre prise en charge comme préconisé par plusieurs auteurs [2,3]. Cette réponse aux antiglaucomateux a été vérifiée par plusieurs séries [4,5] rejoignant les conclusions de notre étude puisque le traitement médical seul était suffisant dans 80,6 % des cas. Les produits topiques doivent être utilisés avec précaution à cause des conservateurs.…”

Challenges in the complex management of post-keratoplasty glaucoma

“…66,71 The topical medical therapy remains the first-line treatment for post-keratoplasty glaucoma, independently of the technique of corneal transplantation and equally to general glaucoma medical treatment. 66,68,72,73 Most cases with post-keratoplasty glaucoma respond positively to medical treatment; 25,66,68,74 however, adverse side effects of some eye drops and effects on graft failure, long-term survival, and optical clarity should be discussed. The commonly used beta-adrenergic blockers, such as Timolol, may cause a decrease in corneal epithelial barrier function and dry-eyelike surface changes.…”